NASDAQ

FIT Biotech Oy: FIT Biotech Ltd’s own equity negative in the end of November

FIT Biotech OyCompany release December 19, 2017 at 3 pm EET            DRAFT                      FIT Biotech Ltd's ...

FIT Biotech Oy: FIT Biotech Oy:n oma pääoma negatiivinen marraskuun lopussa

FIT Biotech OyYhtiötiedote 19.12.2017 kello 15.00                               DRAFT FIT Biotech Oy:n oma pääoma negatiivinen marraskuun ...

FIT Biotech Oy: FIT Biotech Ltd’s own equity negative in the end of November

FIT Biotech OyCompany release December 19, 2017 at 3 pm EET            DRAFT                      FIT Biotech Ltd's ...

FIT Biotech Oy: FIT Biotech Oy:n oma pääoma negatiivinen marraskuun lopussa

FIT Biotech OyYhtiötiedote 19.12.2017 kello 15.00                               DRAFT FIT Biotech Oy:n oma pääoma negatiivinen marraskuun ...

Delcath Announces Preliminary Safety Analysis for Phase 3 Focus Trial  

NEW YORK, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional ...

Delcath Announces Preliminary Safety Analysis for Phase 3 Focus Trial  

NEW YORK, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional ...

Delcath Announces Preliminary Safety Analysis for Phase 3 Focus Trial  

NEW YORK, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional ...

Delcath Announces Preliminary Safety Analysis for Phase 3 Focus Trial  

NEW YORK, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional ...

Delcath Announces Preliminary Safety Analysis for Phase 3 Focus Trial  

NEW YORK, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional ...